Quest/Unilab
This article was originally published in The Gray Sheet
Executive Summary
Quest Diagnostics will submit more information on its proposed acquisition of diagnostic testing services firm Unilab following a request from the Federal Trade Commission. Completion of the $1.1 bil. purchase, first announced April 2, is expected to be delayed until the third quarter (1"The Gray Sheet" April 8, 2002, p. 19)...
You may also be interested in...
LabCorp Enhances Cancer Testing Capability With $600 Mil. Dianon Purchase
LabCorp says it does not foresee antitrust issues with the Federal Trade Commission related to the acquisition of cancer testing firm Dianon
Quest Diagnostics Spends $1.6 Bil. To Expand Presence In California, D.C.
Quest Diagnostics will control 12% of the $3.8 bil. California lab testing market following the acquisition of Unilab Corp. The $1.1 bil. deal was announced April 2, one day after Quest completed its $500 mil. cash acquisition of Amercian Medical Labs (AML)
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.